acetazolamide has been researched along with Cognition Disorders in 16 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Murine typhus is a systemic febrile illness caused by Rickettsia typhi, a gram-negative, obligate intracellular bacterium." | 2.50 | Murine typhus as a cause of cognitive impairment: case report and a review of the literature. ( Bergamo, DF; Carr, SB; Emmanuel, PJ; Ferreira, JA, 2014) |
| "Patients with non-communicating hydrocephalus received ventriculo-peritoneal shunts shortly after admission while communicating hydrocephalus was treated with oral acetazolamide (100 mg/kg/day) and furosemide (1 mg/kg/day) in 3-4 divided doses." | 1.31 | Long-term follow up of childhood tuberculous meningitis. ( Burger, M; Donald, P; Fertig, G; Schoeman, J; Springer, P; van Rensburg, AJ; van Zyl, F; Wait, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Roder, C | 1 |
| Haas, P | 1 |
| Fudali, M | 1 |
| Milian, M | 1 |
| Ernemann, U | 1 |
| Meyer, PT | 1 |
| Tatagiba, M | 1 |
| Khan, N | 1 |
| Carr, SB | 1 |
| Bergamo, DF | 1 |
| Emmanuel, PJ | 1 |
| Ferreira, JA | 1 |
| Yoshida, K | 2 |
| Ogasawara, K | 1 |
| Saura, H | 1 |
| Saito, H | 1 |
| Kobayashi, M | 1 |
| Terasaki, K | 1 |
| Fujiwara, S | 1 |
| Ogawa, A | 1 |
| Uekawa, K | 1 |
| Hasegawa, Y | 1 |
| Senju, S | 1 |
| Nakagata, N | 1 |
| Ma, M | 1 |
| Nakagawa, T | 1 |
| Koibuchi, N | 1 |
| Kim-Mitsuyama, S | 1 |
| Kai, Y | 1 |
| Ito, K | 1 |
| Kinjo, T | 1 |
| Hokama, Y | 1 |
| Nagamine, H | 1 |
| Kushi, S | 1 |
| Kinjo, S | 1 |
| Tsuchida, Y | 1 |
| Sugimoto, K | 1 |
| Morioka, M | 1 |
| Yano, S | 1 |
| Ohmori, Y | 1 |
| Kawano, T | 1 |
| Nakamura, H | 1 |
| Makino, K | 1 |
| Hamada, J | 1 |
| Kuratsu, J | 1 |
| Yoshii, Y | 1 |
| Calviere, L | 2 |
| Catalaa, I | 2 |
| Marlats, F | 2 |
| Viguier, A | 1 |
| Bonneville, F | 2 |
| Cognard, C | 1 |
| Larrue, V | 2 |
| Ssi Yan Kai, G | 1 |
| Farid, K | 1 |
| Petras, S | 1 |
| Ducasse, V | 1 |
| Chokron, S | 1 |
| Helft, G | 1 |
| Blacher, J | 1 |
| Caillat-Vigneron, N | 1 |
| Schoeman, J | 1 |
| Wait, J | 1 |
| Burger, M | 1 |
| van Zyl, F | 1 |
| Fertig, G | 1 |
| van Rensburg, AJ | 1 |
| Springer, P | 1 |
| Donald, P | 1 |
| Barkai, G | 1 |
| Goshen, E | 1 |
| Tzila Zwas, S | 1 |
| Dolberg, OT | 1 |
| Pick, CG | 1 |
| Bonne, O | 1 |
| Schreiber, S | 1 |
| García-Gascó, P | 1 |
| Salame Gamarra, F | 1 |
| Tenllado Doblas, P | 1 |
| Chazarra Talens, C | 1 |
| White, AJ | 1 |
| Vos, PJ | 1 |
| Folgering, HT | 1 |
| van Herwaarden, CL | 1 |
| Knapp, WH | 1 |
| Dannenberg, C | 1 |
| Marschall, B | 1 |
| Zedlick, D | 1 |
| Löschmann, K | 1 |
| Bettin, S | 1 |
| Barthel, H | 1 |
| Seese, A | 1 |
| Sterzer, P | 1 |
| Meintzschel, F | 1 |
| Rösler, A | 1 |
| Lanfermann, H | 1 |
| Steinmetz, H | 1 |
| Sitzer, M | 1 |
| Sørensen, PS | 1 |
| Thomsen, AM | 1 |
| Gjerris, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-blind Randomized Acetazolamide Trial in Normal Pressure Hydrocephalus[NCT04975269] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-02-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for acetazolamide and Cognition Disorders
| Article | Year |
|---|---|
Murine typhus as a cause of cognitive impairment: case report and a review of the literature.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Brain; Chronic Disease; Cognition Disorders; Diagnosis, | 2014 |
Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairment.
Topics: Acetazolamide; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Disorders; Cognition Disorders; | 2012 |
4 trials available for acetazolamide and Cognition Disorders
| Article | Year |
|---|---|
Cognitive impairment of acute mountain sickness and acetazolamide.
Topics: Acetazolamide; Adult; Altitude; Cognition; Cognition Disorders; Female; Humans; Hypoxia; Male; Psych | 1984 |
Visual attention in patients with chronic obstructive pulmonary disease.
Topics: Acetazolamide; Aged; Anticonvulsants; Attention; Chlormadinone Acetate; Cognition Disorders; Female; | 1995 |
Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function.
Topics: Acetazolamide; Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Fem | 1996 |
Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease.
Topics: Acetazolamide; Aged; Blood Flow Velocity; Cholesterol, LDL; Cognition Disorders; Dementia, Vascular; | 2001 |
10 other studies available for acetazolamide and Cognition Disorders
| Article | Year |
|---|---|
Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
Topics: Acetazolamide; Adolescent; Adult; Aged; Cerebrovascular Circulation; Cognition Disorders; Cohort Stu | 2020 |
Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Topics: Acetazolamide; Aged; Brain; Carotid Stenosis; Cerebrovascular Circulation; Cognition Disorders; Coho | 2015 |
Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.
Topics: Acetazolamide; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Animals; Avoidance Learning; | 2016 |
Reversibility of cognitive disorder after treatment of dural arteriovenous fistulae.
Topics: Acetazolamide; Aged; Brain; Central Nervous System Vascular Malformations; Cerebral Angiography; Cog | 2009 |
Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Cerebrovascular Circulation; Cognition Disorders; Execu | 2010 |
Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter.
Topics: Acetazolamide; Adult; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Executive Function; | 2012 |
Long-term follow up of childhood tuberculous meningitis.
Topics: Acetazolamide; Anti-Inflammatory Agents; Antitubercular Agents; Brain; Child; Cognition Disorders; D | 2002 |
Acetazolamide-enhanced neuroSPECT scan reveals functional impairment after minimal traumatic brain injury not otherwise discernible.
Topics: Acetazolamide; Adult; Brain; Brain Injuries; Carbonic Anhydrase Inhibitors; Cognition Disorders; Hum | 2004 |
[Complete resolution of chronic hydrocephalus of adult with acetazolamide].
Topics: Acetazolamide; Aged; Brain; Carbonic Anhydrase Inhibitors; Chronic Disease; Cognition Disorders; Fem | 2005 |
Persistent disturbances of cognitive functions in patients with pseudotumor cerebri.
Topics: Acetazolamide; Adolescent; Adult; Cognition Disorders; Female; Follow-Up Studies; Humans; Learning; | 1986 |